Clinical trial
Novel Peptides in Resistant Human Hypertension
NCT01514357 is registered in ClinicalTrials.gov with John C Burnett as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Peptides in Resistant Human Hypertension
- Lead sponsor
- John C Burnett
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- April 30, 2012
- Completion date
- July 31, 2014
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.